| Title | Chinese Journal of Pharmacovigilance |
| Abbreviation | Chin. J. Pharmacovigil. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Toxicology (Q4) |
| h-index | 7 |
| Overall Rank/Ranking | 25069 |
| SCImago Journal Rank (SJR) | 0.143 |
| Impact Score | 0.36 |
| Publisher | |
| Country | China |
| ISSN | 16728629 |
| Best Quartile | Q4 |
| Coverage History | 2020-2025 |
Chinese Journal of Pharmacovigilance is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Toxicology (Q4). It is published by . The overall rank of Chinese Journal of Pharmacovigilance is 25069. According to SCImago Journal Rank (SJR), this journal is ranked 0.143. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 7. The best quartile for this journal is Q4.
The ISSN of Chinese Journal of Pharmacovigilance journal is 16728629. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Chinese Journal of Pharmacovigilance is cited by a total of 269 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Chinese Journal of Pharmacovigilance is 0.36, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Chinese Journal of Pharmacovigilance is 0.36. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.36 |
Chinese Journal of Pharmacovigilance has an h-index of 7. It means 7 articles of this journal have more than 7 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Chinese Journal of Pharmacovigilance is 16728629. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Chinese Journal of Pharmacovigilance is 25069. According to SCImago Journal Rank (SJR), this journal is ranked 0.143. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.143 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 25069 |
Chinese Journal of Pharmacovigilance is published by . It's publishing house is located in China. Coverage history of this journal is as following: 2020-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Chinese Journal of Pharmacovigilance is Chin. J. Pharmacovigil.. This abbreviation ('Chin. J. Pharmacovigil.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Toxicology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Chinese Journal of Pharmacovigilance latest impact IF is 0.36. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.36 (2024) and 0.36 (2024), respectively, in the last 1 year. Moreover, its average IS is 0.36 in the previous 1 year.
The Chinese Journal of Pharmacovigilance has an SJR (SCImago Journal Rank) of 0.143, according to the latest data. It is computed in the year 2025. In the past 1 years, this journal has recorded a range of SJR, with the highest being 0.143 in 2024 and the lowest being 0.143 in 2024. Furthermore, the average SJR of the Chinese Journal of Pharmacovigilance over the previous 1-year period stands at 0.36.
The latest h-index of the Chinese Journal of Pharmacovigilance is 7.
The Chinese Journal of Pharmacovigilance is published by the , with its country of publication being the China.
The Chinese Journal of Pharmacovigilance is currently ranked 25069 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 1 year, this journal has experienced varying rankings, reaching its highest position of 25069 in 2024 and its lowest position of 25069 in 2024.
The standard ISO4 abbreviation for the Chinese Journal of Pharmacovigilance is Chin. J. Pharmacovigil..
Chinese Journal of Pharmacovigilance is classified as a journal that the publishes.
The Chinese Journal of Pharmacovigilance encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Chinese Journal of Pharmacovigilance is assigned the following International Standard Serial Numbers (ISSN): 16728629.
The best quartile for the Chinese Journal of Pharmacovigilance is Q4 (2024).
The Chinese Journal of Pharmacovigilance coverage history can be summarized as follows: 2020-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| International Journal of Applied Linguistics | journal | 6655 | Wiley-Blackwell Publishing Ltd | 57 | 2.61 |
| Archives of the Balkan Medical Union | journal | 26504 | Balkan Medical Union | 13 | 0.20 |
| Proceedings of the Royal Society of Queensland | journal | 28017 | Royal Society of Queensland | 12 | 0.17 |
| International Journal of Press/Politics | journal | 833 | SAGE Publications Inc. | 87 | 8.82 |
| Metascience | journal | 24313 | Springer Nature | 3 | 0.00 |
| East African journal of public health | journal | 19634 | East African Public Health Association | 23 | 0.00 |
| American Journal of Immunology (discontinued) | journal | 19764 | Science Publications | 12 | 1.56 |
| Journal on Chain and Network Science | journal | 11905 | Wageningen Academic Publishers | 24 | 0.00 |
| Brain Imaging and Behavior | journal | 4582 | Springer New York | 72 | 2.86 |
| Structure and Infrastructure Engineering | journal | 5892 | Taylor and Francis Ltd. | 76 | 3.75 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.36 |
